Literature DB >> 3862095

In vitro screening assay for teratogens using growth inhibition of human embryonic cells.

R M Pratt, W D Willis.   

Abstract

We have tested 35 teratogenic and 20 nonteratogenic chemicals or drugs in a short-term, in vitro assay that identifies teratogens by their ability to inhibit growth of an established line of human embryonic palatal mesenchymal cells. Only those chemicals that exhibited a dose-dependent inhibition of growth at concentrations less than 1 mM were classified as inhibitory. An Aroclor-induced rat liver S-9 system was effective in metabolizing cyclophosphamide to its teratogenic form in culture. We suggest that this assay, along with the complementary tumor cell-attachment assay of Braun et al. [Braun, A. G., Emerson, D. J. & Nichinson, B. B. (1979) Nature (London) 282, 507-509] may be useful as a short-term in vitro battery for assessment of the teratogenic potential in environmental agents and to prioritize those chemicals which merit further testing in vivo.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3862095      PMCID: PMC390638          DOI: 10.1073/pnas.82.17.5791

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

Review 1.  Review of in vitro systems with potential for use in teratogenicity screening.

Authors:  J G Wilson
Journal:  J Environ Pathol Toxicol       Date:  1978 Sep-Oct

2.  A selection of candidate compounds for in vitro teratogenesis test validation.

Authors:  M K Smith; G L Kimmel; D M Kochhar; T H Shepard; S P Spielberg; J G Wilson
Journal:  Teratog Carcinog Mutagen       Date:  1983

3.  Prescreening for environmental teratogens using cultured mesenchymal cells from the human embryonic palate.

Authors:  R M Pratt; R I Grove; W D Willis
Journal:  Teratog Carcinog Mutagen       Date:  1982

4.  Overview of In Vitro Teratogenicity Testing: aspects of validation and application to screening.

Authors:  G L Kimmel; K Smith; D M Kochhar; R M Pratt
Journal:  Teratog Carcinog Mutagen       Date:  1982

5.  Quantitative correspondence between the in vivo and in vitro activity of teratogenic agents.

Authors:  A G Braun; C A Buckner; D J Emerson; B B Nichinson
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

Review 6.  Screening for teratogenic hazards: nature of the problems.

Authors:  E M Johnson
Journal:  Annu Rev Pharmacol Toxicol       Date:  1981       Impact factor: 13.820

7.  Teratogenicity of cyclophosphamide in a coupled microsomal activating/embryo culture system.

Authors:  K T Kitchin; B P Schmid; M K Sanyal
Journal:  Biochem Pharmacol       Date:  1981-01-01       Impact factor: 5.858

8.  Teratogenic bioactivation of cyclophosphamide in vitro.

Authors:  A G Fantel; J C Greenaway; M R Juchau; T H Shepard
Journal:  Life Sci       Date:  1979-07-02       Impact factor: 5.037

9.  Teratogenic drugs inhibit tumour cell attachment to lectin-coated surfaces.

Authors:  A G Braun; D J Emerson; B B Nichinson
Journal:  Nature       Date:  1979-11-29       Impact factor: 49.962

10.  Teratogen metabolism: activation of thalidomide and thalidomide analogues to products that inhibit the attachment of cells to concanavalin A coated plastic surfaces.

Authors:  A G Braun; S L Weinreb
Journal:  Biochem Pharmacol       Date:  1984-05-01       Impact factor: 5.858

View more
  3 in total

1.  Evaluation of Cytotoxic Effects of Dichloromethane Extract of Guduchi (Tinospora cordifolia Miers ex Hook F & THOMS) on Cultured HeLa Cells.

Authors:  Ganesh Chandra Jagetia; Shaival Kamalaksha Rao
Journal:  Evid Based Complement Alternat Med       Date:  2006-04-24       Impact factor: 2.629

Review 2.  Teratological research using in vitro systems. IV. Cells in culture.

Authors:  J J Welsh
Journal:  Environ Health Perspect       Date:  1987-06       Impact factor: 9.031

3.  Comparison of cantharidin toxicity in breast cancer cells to two common chemotherapeutics.

Authors:  Katie M Kern; Jennifer R Schroeder
Journal:  Int J Breast Cancer       Date:  2014-09-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.